From Botox and lasers to energy-based skin tightening, beauty journalist Alice Hart-Davis has tried it all—so you don’t have to. In this deep dive, she dishes on her fave tweakments, the ones she ...
AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.
By Prof. Raphael Nyarkotey OBU Hibiscus, locally known as “sobolo” in Ghana, holds immense potential to generate significant revenue for the country due to its versatility and growing demand both ...